News | January 26, 2021
Aurobindo Pharma gets approval for 3 products under PLI Scheme: ICICI Securities
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
The company is expecting tremendous growth and a better quarterly performance
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
Subscribe To Our Newsletter & Stay Updated
